Delayed surgery increases cancer risk
Article written by Gary Finnegan. The rescheduling of surgeries early in the COVID-19 pandemic has had a significant impact on cancer survival rates.
Article written by Gary Finnegan. The rescheduling of surgeries early in the COVID-19 pandemic has had a significant impact on cancer survival rates.
Article written by Bruce Sylvester. HPV (human papillomavirus) vaccination appears to significantly lower the risk of cervical cancer, researchers reported on Sept. 30, 2020 in the NEJM/New England… read more.
Article written by Bruce Sylvester Researchers report that capmatinib, a targeted therapy, appears to provide clinical benefit to patients who have advanced lung cancer with specific gene mutations.
Among women with breast cancer, colorectal cancer, or melanoma, those who were taking cholesterol-lowering medications, were less likely to die from cancer, according to an analysis published in… read more.
Article written by Bruce Sylvester Dabrafenib plus trametinib combination appears to be a promising treatment for patients with bile duct cancer (biliary tract cancer) with BRAF V600E mutations. Researchers… read more.
Article written by Bruce Sylvester. Coffee consumption by patients with metastatic colorectal cancer is associated with longer survival, researchers reported on Sept. 17, 2020 in JAMA Oncology.
Interview and article by Christine Clark During the pandemic the oncology pharmacy service at Velindre Cancer Centre demonstrated its ability to react rapidly to service demands and to… read more.
Article written by Bruce Sylvester Patients being treated with angiotensin converting enzyme inhibitors (ACE-i) or angiotensin II receptor blockers (ARBs) for high blood pressure and other conditions appear… read more.
Article written by Bruce Sylvester Investigators have validated a first-line combination therapy that significantly improves survival in patients with hepatocellular carcinoma, the most common liver cancer.
Article written by Bruce Sylvester
The majority of patients with follicular lymphoma (FL) have excellent results when treated with chemotherapy so — even with evolving understanding of disease biology and availability of a parade… read more.
Professor Stephen Ansell (Rochester, USA) discusses the DIAL study
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.